Neuphoria Therapeutics Inc (NEUP) Stock Price & News

Analyst	Recommendation	Action	Price target	Projected	Date
Joseph Pantginis H.C. Wainwright	Hold	Maintained	-	-	07/27/2026
Jason McCarthy Maxim Group	Buy	Maintained	$20.00	+438.4%	10/30/2025
Elemer Piros Lucid Capital	Hold	Downgraded	$2.30	-38.1%	10/21/2025

Finance


Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale